TNF and rheumatoid arthritis: Building on the evidence for the central effects of TNF blockade, JAK inhibitors have also demonstrated striking analgesic benefits in RA, further highlighting the potential for immune‐targeted therapies to modulate pain beyond their anti‐inflammatory effects.58